Panbela enters sponsored research agreement to explore polyamines for immune modulation in hematologic malignancies
June 14, 2023
Panbela Therapeutics Inc. has entered into a sponsored research agreement with The University of Texas MD Anderson Cancer Center for the evaluation of polyamine metabolic inhibitor...